The Enterprise Value as of October 2024 (TTM) for Genetic Technologies Limited (GENE) is 9.11M

According to Genetic Technologies Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 9.11M. This represents a change of -98.24% compared to the average of 516.85M of the last 4 quarters.

Genetic Technologies Limited (GENE) Historical Enterprise Value (quarterly & annually)

How has GENE Enterprise Value performed in the past?

The mean historical Enterprise Value of Genetic Technologies Limited over the last ten years is 570.75M. The current 9.11M Enterprise Value has changed 59.68% with respect to the historical average. Over the past ten years (40 quarters), GENE's Enterprise Value was at its highest in in the June 2021 quarter at 2.51B. The Enterprise Value was at its lowest in in the June 2024 quarter at 314.20M.

Genetic Technologies Limited (GENE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Genetic Technologies Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Genetic Technologies Limited (GENE) Average Enterprise Value

How has GENE Enterprise Value performed in the past?

The current Enterprise Value of Genetic Technologies Limited (GENE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Genetic Technologies Limited (GENE) Enterprise Value vs. Peers

How is GENE’s Enterprise Value compared to its peers?

Genetic Technologies Limited’s Enterprise Value is greater than Biocept, Inc. (4.96M), less than T2 Biosystems, Inc. (29.85M), greater than HTG Molecular Diagnostics, Inc. (2.05M), greater than Intelligent Bio Solutions Inc. (474.54K), less than Interpace Biosciences, Inc. (17.16M), less than bioAffinity Technologies, Inc. (19.06M), less than SeqLL Inc. (264.18M), less than Agilent Technologies, Inc. (40.48B), less than Sera Prognostics, Inc. (0), less than Precipio, Inc. (249.74M), less than MDxHealth SA (9.23M), less than null (138.27M),

Build a custom stock screener for Genetic Technologies Limited (GENE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Genetic Technologies Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Genetic Technologies Limited (GENE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Genetic Technologies Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.